Labcycler targets 600,000 PCR cycles in a compact lab instrument

By Grace Kim

Labcycler, Diatech Pharmacogenetics' compact PCR thermal cycler, is designed for up to 600,000 cycles—roughly 20 years of laboratory use, according to the company. The announcement gives no test conditions for that endurance claim and publishes no numerical accuracy tolerance, temperature uniformity, block capacity or calibration interval.

What does the acquisition change?

Diatech acquired Germany-based SensoQuest, which originally developed Labcycler, and now manages manufacturing and development at its facility in Jesi, Italy. The release says this move will make the instrument available to a broader market. It provides no acquisition date or transaction terms, and states that Labcycler is available now through diatechpharmacogenetics.com.

The release frames that division as German engineering heritage combined with Italian manufacturing. The decision followed more than 30 years of R&D in molecular diagnostics and Diatech's own use and evaluation of Labcycler. Diatech cited high reliability and precision, but presented this evidence as internal experience rather than independent testing.

Fabio Biondi, Diatech Pharmacogenetics' president, said: “With the acquisition of SensoQuest and the launch of Labcycler, Diatech is taking a strategic step, from reagents and diagnostic kits to complete solutions for the molecular laboratory.” He described the deal as a move toward complete molecular-laboratory solutions.

Biondi also said: “Precision, reliability and ease of use are what laboratories ask us for every day, and Labcycler delivers them all in a platform built to last.” Diatech provides no independent test report, accuracy tolerance or endurance protocol with that statement.

The deal gives Diatech control of an instrument it had already evaluated.

Where does Labcycler fit in the laboratory?

Labcycler targets routine research and diagnostic laboratories that need reliable nucleic-acid amplification with accurate, reproducible results. The release places that function within molecular analysis supporting earlier, more precise detection in oncology and forensics, as well as veterinary, plant and environmental testing.

Thermal cycling supplies repeated temperature changes for nucleic-acid amplification, so consistent performance across cycles matters as much as the advertised cycle count. Diatech asserts precision, reliability and ease of use, but does not quantify how Labcycler maintains those properties.

Diatech develops, manufactures and commercializes precision-medicine solutions for pathology departments and molecular biology laboratories. Its work includes solid-tumor and liquid-biopsy diagnostics, genetics and pharmacogenetics, with commercial operations in more than 50 countries.

Labcycler broadens Diatech from reagents and kits into laboratory hardware.

What evidence supports the 600,000-cycle claim?

Diatech describes Labcycler as robust, accurate, easy to use and suitable for routine workflows, and presents it as a future-proof investment offering good value. The release gives no price, cost-per-cycle calculation or efficiency comparison to support that commercial positioning.

• Reported endurance: Up to 600,000 cycles, equivalent by Diatech to roughly 20 years of use.
• Test conditions: No cycle profile, ambient temperature, sample load, maintenance schedule or service-life protocol appears behind the figure.
• Missing specifications: The announcement lists no temperature range or resolution, heating and cooling rates, across-block uniformity, block format, sample volume or calibration interval.
• Accuracy basis: Diatech cites its internal use and evaluation, describing the result only as high reliability and precision.
• Validation record: No named test method, standard revision, acceptance criterion or diagnostic validation claim appears in the announcement.

The omissions limit direct comparison with other thermal cyclers and prevent a laboratory from translating the 20-year figure into a service plan. A cycle-count ceiling cannot establish temperature accuracy, repeatability or maintenance needs under the intended workload.

Buyers need test data before they can treat 600,000 cycles as a service-life commitment.

What should laboratories verify before adoption?

Labcycler is available now, but the release gives no price, warranty, order lead time, service plan or country-by-country availability. Diatech's presence in more than 50 countries establishes a commercial network, not a disclosed instrument-support footprint.

Before adoption, laboratories should request quantitative evidence tied to their assays and operating environment. They should also separate manufacturer claims from documented acceptance data.

• Temperature accuracy and across-block uniformity under the intended sample load.
• Compatibility with assay sample volumes and validated cycling protocols.
• Calibration interval, traceability and documented routine-maintenance procedures.
• Regulatory and quality documentation for the intended laboratory use.

Until laboratories have those data, they must judge Labcycler against their own accuracy, reproducibility and compliance requirements. The development therefore raises the adoption question: can Diatech turn its 600,000-cycle claim and internal reliability assessment into published, assay-relevant validation across a market spanning more than 50 countries?